Surrey researchers Sign in
Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial
Journal article   Peer reviewed

Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial

CL White, KR Twigger, L Vidal, JS De Bono, M Coffey, L Heinemann, R Morgan, A Merrick, F Errington, RG Vile, …
GENE THERAPY, Vol.15(12), pp.911-920
01/06/2008

Abstract

Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Biotechnology & Applied Microbiology Genetics & Heredity Medicine Research & Experimental Research & Experimental Medicine BIOCHEMISTRY & MOLECULAR BIOLOGY BIOTECHNOLOGY & APPLIED MICROBIOLOGY GENETICS & HEREDITY MEDICINE RESEARCH & EXPERIMENTAL immune response reovirus neutralizing antibody cytokine T-cell subset phase I trial HIGH-FREQUENCY RAS THERAPY VIRUS PREVALENCE ACTIVATION ADENOVIRUS MUTATIONS PATHWAY CANCERS
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000256355000004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Details

Usage Policy